Pacer Advisors, Inc. Scholar Rock Holding Corp Transaction History

Pacer Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$7.84 - $16.79 $6,711 - $14,372	-856 Reduced 53.1%	756 $6,000
Q1 2024 May 10, 2024	BUY	$13.2 - $17.76 $21,278 - $28,629	1,612 New	1,612 $28,000
Q2 2021 Jul 21, 2021	SELL	$26.34 - $46.62 $29,974 - $53,053	-1,138 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$45.96 - $68.02 $30,425 - $45,029	662 Added 139.08%	1,138 $58,000
Q4 2020 Jan 20, 2021	BUY	$13.72 - $51.57 $6,530 - $24,547	476 New	476 $23,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.